{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:51:31Z","timestamp":1791921091697,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:00:00Z","timestamp":1791072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jiph.2026.103383","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:20:45Z","timestamp":1791501645000},"page":"103383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-dose sulbactam for extensively drug-resistant Acinetobacter baumannii infection in patients with critical illness"],"prefix":"10.1016","volume":"19","author":[{"given":"Jiaxin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunmeng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jiph.2026.103383_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.jiph.2026.103383_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jiph.2023.01.004","article-title":"A two-year retrospective study of multidrug-resistant Acinetobacter baumannii respiratory infections in critically ill patients: clinical and microbiological findings","volume":"16","author":"Hafiz","year":"2023","journal-title":"J Infect Public Health"},{"issue":"1","key":"10.1016\/j.jiph.2026.103383_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40265-024-02104-6","article-title":"Treatment approaches for carbapenem-resistant Acinetobacter baumannii infections","volume":"85","author":"Iovleva","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.jiph.2026.103383_bib4","unstructured":"World Health Organization. WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. 2024. Accessed May 17, 2024. https:\/\/www.who.int\/publications\/i\/item\/ 9789240093461."},{"issue":"3","key":"10.1016\/j.jiph.2026.103383_bib5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiph.2026.103383_bib6","article-title":"Polymyxin B-associated nephrotoxicity and its predictors: a retrospective study in carbapenem-resistant gram-negative bacterial infections","volume":"13","author":"Wu","year":"2022","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.jiph.2026.103383_bib7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3390\/antibiotics10091081","article-title":"Efficacies of colistin-carbapenem versus colistin-tigecycline in critically Ill patients with CR-GNB-associated pneumonia: a multicenter observational study","volume":"10","author":"Wang","year":"2021","journal-title":"Antibiot (Basel)"},{"issue":"2","key":"10.1016\/j.jiph.2026.103383_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01010-21","article-title":"Tigecycline heteroresistance and resistance mechanism in clinical isolates of Acinetobacter baumannii","volume":"9","author":"Jo","year":"2021","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.jiph.2026.103383_bib9","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.04808-14","article-title":"Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii","volume":"59","author":"Penwell","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jiph.2026.103383_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jac\/dkx368","article-title":"Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis","volume":"73","author":"Kengkla","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2026.103383_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jgar.2020.08.021","volume":"24","author":"Liu","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"6","key":"10.1016\/j.jiph.2026.103383_bib12","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s15010-024-02307-9","article-title":"A retrospective study of the efficacy of sulbactam in the treatment of patients with extensively drug-resistant Acinetobacter baumannii infections","volume":"52","author":"Yu","year":"2024","journal-title":"Infection"},{"key":"10.1016\/j.jiph.2026.103383_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2026.103383_bib14","unstructured":"Pfizer Inc. UNASYN\u00ae (ampicillin sodium\/sulbactam sodium) injection, powder for solution [package insert]. Silver Spring (MD): U.S. Food and Drug Administration; 2024. Accessed January 6, 2026. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/050608s053l bl.pdf."},{"issue":"1","key":"10.1016\/j.jiph.2026.103383_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12941-021-00471-6","article-title":"Comparison of therapy with \u03b2-lactam\/\u03b2-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae","volume":"20","author":"Luo","year":"2021","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"8","key":"10.1016\/j.jiph.2026.103383_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jiph.2026.103383_bib17","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/cid\/ciw110","article-title":"Time is of the essence: the impact of delayed antibiotic therapy on patient outcomes in hospital-onset enterococcal bloodstream infections","volume":"62","author":"Zasowski","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2026.103383_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/antibiotics12020273","article-title":"Intravenous polymyxin B as adjunctive therapy to high-dose tigecycline for the treatment of nosocomial pneumonia due to carbapenem-resistant acinetobacter baumannii and klebsiella pneumoniae: a propensity score-matched cohort study","volume":"12","author":"Zha","year":"2023","journal-title":"Antibiot (Basel)"},{"key":"10.1016\/j.jiph.2026.103383_bib19","unstructured":"Clinical and Laboratory Standards Institute. M100: Performance Standards for Antimicrobial Susceptibility Testing. 35th ed. Wayne, PA: CLSI; 2025."},{"issue":"8","key":"10.1016\/j.jiph.2026.103383_bib20","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.cmi.2019.03.014","article-title":"Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment","volume":"25","author":"Piperaki","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"23","key":"10.1016\/j.jiph.2026.103383_bib21","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.jiph.2026.103383_bib22","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"7894","key":"10.1016\/j.jiph.2026.103383_bib23","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-021-04264-x","article-title":"A naturally inspired antibiotic to target multidrug-resistant pathogens","volume":"601","author":"Wang","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jiph.2026.103383_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae052","article-title":"Antimicrobial resistance of clinical bacterial isolates in China: current status and trends","volume":"6","author":"Qin","year":"2024","journal-title":"JAC Antimicrob Resist"},{"issue":"10","key":"10.1016\/j.jiph.2026.103383_bib25","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1007\/s00134-025-08074-x","article-title":"A reappraisal of association between ventilator-associated events and mortality among critically ill patients using marginal structural model: multicenter observational study","volume":"51","author":"Nakahashi","year":"2025","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jiph.2026.103383_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13613-022-01060-2","article-title":"Early antibiotic therapy is associated with a lower probability of successful liberation from mechanical ventilation in patients with severe acute exacerbation of chronic obstructive pulmonary disease","volume":"12","author":"Deniel","year":"2022","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.jiph.2026.103383_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-021-03787-z","article-title":"Timing of antibiotic therapy in the ICU","volume":"25","author":"Kollef","year":"2021","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.jiph.2026.103383_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106880","article-title":"Clinical outcomes and safety of intravenous polymyxin B-based treatment in critically ill patients with carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia","volume":"62","author":"Qiao","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jiph.2026.103383_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13054-023-04792-0","article-title":"Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicenter retrospective cohort study","volume":"28","author":"Barbier","year":"2024","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.jiph.2026.103383_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.29566","article-title":"factors associated with treatment failure in moderately severe community-acquired pneumonia: a secondary analysis of a randomized clinical trial","volume":"4","author":"Dinh","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126002558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126002558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:34:01Z","timestamp":1791920041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034126002558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1876034126002558"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103383","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose sulbactam for extensively drug-resistant Acinetobacter baumannii infection in patients with critical illness","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103383"}}